MedTrace Logo

Calcinosis Cutis: Therapeutic Effects of Extracorporeal Shock Wave Therapy (ESWT)

NCT01683500 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 4

Last updated 2015-06-03

No results posted yet for this study

Summary

Patients with calcinosis cutis due to connective tissue disease get a shock wave therapy. The shock wave therapy will be done in 3 sessions with one week interval. The outcome parameters are: change in pain, size of the calcinosis, of possible ulcers and intake of painkillers.

* Trial with medical device

Conditions

  • Calcinosis Cutis in Connective Tissue Disease

Interventions

DEVICE

shock wave therapy with Modulith SLK (Storz)

Three sessions with shock wave therapy, interval of one week.

Sponsors & Collaborators

  • University of Zurich

    lead OTHER

Principal Investigators

  • Sandra Blumhardt, MD · University Hospital Zurich, Division of Rheumatology

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-08-31
Primary Completion
2014-08-31
Completion
2014-08-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01683500 on ClinicalTrials.gov